Page 384 - Read Online

Marasco et al. Hepatoma Res 2020;6:33 I http://dx.doi.org/10.20517/2394-5079.2020.01 Page 19 of 19

intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Eur J Gastroenterol Hepatol 2011;23:787-
93.
192. Shen H, Zheng S, Chen R, Jin X, Xu X, et al. Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular
carcinoma treated with transcatheter arterial chemoembolization. Medicine (Baltimore) 2017;96:e7438.
193. Liu PH, Hsu CY, Hsia CY, Lee YH, Su CW, et al. Prognosis of hepatocellular carcinoma: assessment of eleven staging systems. J Hepatol
2016;64:601-8.
194. Biselli M, Andreone P, Gramenzi A, Trevisani F, Cursaro C, et al. Transcatheter arterial chemoembolization therapy for patients with
hepatocellular carcinoma: a case-controlled study. Clin Gastroenterol Hepatol 2005;3:918-25.
195. Brown DB, Fundakowski CE, Lisker-Melman M, Crippin JS, Pilgram TK, et al. Comparison of MELD and Child-Pugh scores to predict
survival after chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol 2004;15:1209-18.
196. Testa R, Testa E, Giannini E, Botta F, Malfatti F, et al. Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients
with viral cirrhosis: Role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease
(MELD), in predicting outcome after treatm. Aliment Pharmacol Ther 2003;17:1563-9.
197. Xu L, Peng ZW, Chen MS, Shi M, Zhang YJ, et al. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after
transcatheter arterial chemoembolization. J Hepatol 2015;63:122-30.
198. Sasaki R, Taura N, Miyazoe Y, Yamamichi S, Nakashiki S, et al. Ketone bodies as a predictor of prognosis of hepatocellular carcinoma
after transcatheter arterial chemoembolization. Nutrition 2018;50:97-103.
199. Yu X, Ge N, Guo X, Shen S, Liang J, et al. Genetic variants in the EPCAM gene is associated with the prognosis of transarterial
chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombus. PLoS One 2014;9:e93416.
200. Hu W, Huang S, Dong L, Yu C, Li C, et al. MDR1 gene polymorphism correlated with pathological characteristics and prognosis in
patients with primary hepatocellular carcinoma receiving interventional therapy. Anticancer Drugs 2019;30:233-40.
201. Zhang H, Guo X, Dai J, Wu Y, Ge N, et al. Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular
carcinoma patients. Med Oncol 2014;31:1-8.
202. Liang KH, Lin CL, Chen SF, Chiu CW, Yang PC, et al. GALNT14 genotype effectively predicts the therapeutic response in unresectable
hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Pharmacogenomics 2016;17:353-66.
203. Wang G, Bi C. Correlations of pri-Let-7 gene polymorphisms with the recurrence and metastasis of primary liver cancer after
transcatheter arterial chemoembolization. Pathol Res Pract 2018;214:667-72.
204. Fako V, Martin SP, Pomyen Y, Budhu A, Chaisaingmongkol J, et al. Gene signature predictive of hepatocellular carcinoma patient
response to transarterial chemoembolization. Int J Biol Sci 2019;15:2654-63.
205. Spârchez Z, Mocan T, Radu P, Anton O, Comsa M, et al. Contrast enhanced ultrasonography in assessing the treatment response to
transarterial chemoembolization in patients with hepatocellular carcinoma. Med Ultrason 2016;18:96-102.
206. Sung SA, Kim MJ, Joon SL, Hong HS, Yong EC, et al. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the
diagnosis of hepatocellular carcinoma. Radiology 2010;255:459-66.
207. Hwang J, Kim SH, Kim YS, Lee MW, Woo JY, et al. Gadoxetic acid-enhanced MRI versus multiphase multidetector row computed
tomography for evaluating the viable tumor of hepatocellular carcinomas treated with image-guided tumor therapy. J Magn Reson
Imaging 2010;32:629-38.
208. Tacher V, Lin M, Duran R, Yarmohammadi H, Lee H, et al. Comparison of existing response criteria in patients with hepatocellular
carcinoma treated with transarterial chemoembolization using a 3D quantitative approach. Radiology 2016;278:275-84.